Injective [INJ] traded back above $5 as the token attempted to extend its recovery from June lows, with buyers now facing resistance around the $5.20 region.
The latest price move comes as Injective filed its transfer agent registration with the U.S. Securities and Exchange Commission [SEC]. This is part of the blockchain network’s push to bring on-chain regulated real-world assets [RWAs] and securities infrastructure.
Injective files for SEC transfer-agent registration
Injective announced on July 16 that it had officially filed its transfer agent registration with the SEC.
Transfer agents maintain official ownership records for securities and process changes when those assets change hands. Injective wants to bring this function on-chain, allowing the ownership record to exist on the same blockchain as the tokenized security rather than relying on a separate off-chain database.
According to Injective, moving the transfer-agent function on-chain could allow market participants to record and transfer ownership of tokenized securities within seconds while reducing the need for multiple intermediaries to reconcile transactions.
The filing begins the registration process and should not be interpreted as SEC approval or confirmation that Injective is already operating as a registered transfer agent.
Regulatory push extends beyond the U.S.
The SEC filing forms part of Injective’s broader push to expand its regulated financial infrastructure.
Injective said the announcement came hours after it published its MiCAR whitepaper, which the project says will support its expansion across European Union member states within the region’s regulatory framework.
Together, the developments highlight Injective’s efforts to position its blockchain infrastructure for institutional and regulated markets across the U.S. and Europe.
However, the developments have yet to trigger a decisive breakout for INJ.
Can INJ break above $5.20?
At press time, INJ was trading at approximately $5.05, with the latest 12-hour candle gaining around 2.5%.
The token has recovered considerably since falling towards $4.10 in late June. However, its price action throughout July has largely remained within a consolidation range between approximately $4.50 and $5.20.
The Relative Strength Index [RSI] stood at 56.20, above the neutral 50 level, suggesting that buying momentum had strengthened. However, the indicator remained well below overbought territory, leaving room for further upside if demand increases.
The immediate challenge is the $5.20 region, which has repeatedly limited INJ’s recovery attempts during July. A decisive move above this area could signal a breakout from the recent consolidation range and strengthen the case for an extended recovery.
Failure to overcome the resistance, however, could leave INJ range-bound and expose the token to another test of support around the lower end of its recent trading range.
Final Summary
- Injective has filed for SEC transfer-agent registration to bring official ownership records for tokenized securities on-chain.
- INJ has recovered above $5 with its RSI rising to 56.20. Still, the token must overcome resistance around $5.20 to confirm a breakout from its July consolidation range.
